Gamelin Erick sold ACRV
November 14, 2025 · Form 4 insider transaction
Gamelin Erick sold 403 shares of Acrivon Therapeutics, Inc. at $2.24 per share, a transaction worth $902.72. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
403
Price
$2.24
Total value
$902.72
InsiderGamelin Erick
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateNovember 14, 2025
Filing dateNovember 18, 2025
Shares owned after15,283
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.